E-LIB Suche - Ergebnisse für: Papp, K K

1

Efficacy and safety of piclidenoson in plaque psoriasis: Re..:

Papp, K. A. ; Beyska‐Rizova, S. ; Gantcheva, M. L....
Journal of the European Academy of Dermatology and Venereology. 38 (2024) 6 - p. 1112-1120 , 2024

Link: https://doi.org/10.1111/..

2

Tofacitinib efficacy, patient‐reported outcomes and safety ..:

Bachelez, H. ; Griffiths, C. E. M. ; Papp, K. A....
Journal of the European Academy of Dermatology and Venereology. 38 (2024) 7 - p. , 2024

Link: https://doi.org/10.1111/..

3

P1081 Pharmacokinetics and immunogenicity of the ustekinuma..:

Chow, V ; Mytych, D T ; Blauvelt, A...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1943-i1943 , 2024

Link: https://doi.org/10.1093/..

4

Abrocitinib effect on patient‐reported outcomes in patients..:

Reich, K. ; Silverberg, J. I. ; Papp, K. A....
Journal of the European Academy of Dermatology and Venereology. 37 (2023) 10 - p. 2047-2055 , 2023

Link: https://doi.org/10.1111/..

5

CO136 Efficacy and Safety of Roflumilast Cream 0.15% in Adu..:

Simpson, E. ; Eichenfield, L.F. ; Gooderham, M....
Value in Health. 26 (2023) 6 - p. S40 , 2023

Link: https://doi.org/10.1016/..

6

Expert consensus on the systemic treatment of atopic dermat..:

Adam, D. N. ; Gooderham, M. J. ; Beecker, J. R....
Journal of the European Academy of Dermatology and Venereology. 37 (2023) 6 - p. 1135-1148 , 2023

Link: https://doi.org/10.1111/..

7

CO230 Efficacy and Safety of Roflumilast Foam 0.3% in Patie..:

Blauvelt, A. ; Draelos, Z.D. ; Gooderham, M....
Value in Health. 26 (2023) 6 - p. S59 , 2023

Link: https://doi.org/10.1016/..

8

Views about perceived training needs of health care profess..:

Papadopoulos, Irena ; Koulouglioti, C. ; Lazzarino, R....
Contemporary Nurse. 59 (2023) 4-5 - p. 344-361 , 2023

Link: https://doi.org/10.1080/..

9

CO45 Durability of Efficacy and Safety of Roflumilast Cream..:

Lebwohl, M. ; Stein Gold, L. ; Gooderham, M....
Value in Health. 26 (2023) 6 - p. S22-S23 , 2023

Link: https://doi.org/10.1016/..

10

Dupilumab treatment in adult patients is efficacious regard..:

Silverberg, J.I. ; Papp, K.A. ; De La Cueva, P....
Revue Française d'Allergologie. 62 (2022) 3 - p. 324-325 , 2022

Link: https://doi.org/10.1016/..

11

Efficacité et tolérance à long terme de l'upadacitinib chez..:

Mease, P.J. ; Setty, A. ; Papp, K....
Revue du Rhumatisme. 89 (2022) - p. A185-A186 , 2022

Link: https://doi.org/10.1016/..

12

The effect of risankizumab on achieving minimal clinically ..:

Kristensen, L.E. ; Soliman, A.M. ; Papp, K....
Journal of the European Academy of Dermatology and Venereology. 36 (2022) 11 - p. 2120-2129 , 2022

Link: https://doi.org/10.1111/..

13

Treatment satisfaction, safety and effectiveness of adding ..:

Papp, K.A. ; Gooderham, M.J. ; Albrecht, L.E...
British Journal of Dermatology. 186 (2022) 4 - p. 726-728 , 2022

Link: https://doi.org/10.1111/..

14

Effects of risankizumab on nail psoriasis in patients with ..:

Kristensen, L.E. ; Soliman, A.M. ; Papp, K....
Journal of the European Academy of Dermatology and Venereology. 36 (2022) 5 - p. , 2022

Link: https://doi.org/10.1111/..

15

Real‐world effectiveness of adalimumab in patients with mod..:

Gulliver, W. ; Alavi, A. ; Wiseman, M.C....
Journal of the European Academy of Dermatology and Venereology. 35 (2021) 12 - p. 2431-2439 , 2021

Link: https://doi.org/10.1111/..